MRM Health and Biocodex Join Forces to Support CORAL-Based Medicines
Thursday, 5 November 2026, 04:59
MRM Health and Biocodex announce a supply partnership
MRM Health and Biocodex have established a strategic partnership focused on strengthening future commercial supply capabilities for medicines based on CORAL®. The announcement describes a collaboration that combines MRM Health’s microbiome science with Biocodex’s capabilities.
What the collaboration aims to do
- Focus: Support future commercial supply for CORAL-based medicines.
- Partners: MRM Health and Biocodex.
- Scientific area: Microbiome-based medicines.
Details available in the announcement
The supplied information does not specify launch timelines, manufacturing arrangements, product indications, or other operational terms. Those details should not be inferred from the partnership announcement alone.
- Review the original announcement for further information.
- Look for future updates from MRM Health and Biocodex on the partnership’s development.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.